Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,254,062
-$127,614 QoQ
Shares Held
52,079
+5.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,189
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Douglass Winthrop Advisors, LLC holds $62,081,020 across 7 Drug Manufacturers - General names. PFE ranks #6 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
22,774 | $27,315,821 | |
| 2 | JNJ |
Johnson & Johnson
|
104,526 | $26,546,468 | |
| 3 | AMGN |
Amgen Inc
|
8,961 | $3,244,957 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
27,548 | $1,587,315 | |
| 5 | NVS |
Novartis AG
|
8,755 | $1,372,083 | |
| 6 | PFE |
Pfizer Inc
This page
|
52,079 | $1,254,062 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
6,018 | $760,314 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,254,062 | 52,079 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,381,676 | 49,205 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,288,998 | 51,767 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,161,098 | 45,569 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,750,903 | 72,232 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,097,543 | 82,776 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,275,637 | 85,776 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,392,679 | 48,123 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,155,769 | 41,307 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $1,255,604 | 45,247 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,399,395 | 48,607 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,822,293 | 54,938 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,198,489 | 59,937 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,531,109 | 62,037 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,149,825 | 61,472 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,706,074 | 61,839 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $3,242,218 | 61,839 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,992,513 | 57,804 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,401,516 | 57,604 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,269,164 | 52,759 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,082,998 | 53,192 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $1,933,957 | 53,380 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,999,335 | 54,315 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $1,918,233 | 52,268 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,728,458 | 52,858 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $1,551,311 | 47,528 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||